Eton Pharmaceuticals Stock Jumps 38% as Guidance Reset Tests Valuation
Eton Pharmaceuticals surged to a record on Friday. The rare-disease drugmaker paired a large sales beat with higher annual guidance. Shares traded at $56.40 at 11:19 EDT, up $15.60.
Company hubNASDAQ:ETON
Eton Pharmaceuticals (ETON) Stock News & Analysis
Follow the latest Eton Pharmaceuticals (ETON) company news, earnings coverage and investor analysis from TechStock².
Save this hub to your TS2 Signalbook account.
- Latest update
- Articles in this hub
- 1
- Last 30 days
- 1
What investors are watching
- Earnings, guidance and financial performance
- Valuation, trading activity and market sentiment
- Strategy, catalysts and company-specific risks
TechStock² Updates
